Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 7 of 60 for:    ALECTINIB

Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03271554
Recruitment Status : Active, not recruiting
First Posted : September 5, 2017
Last Update Posted : April 28, 2021
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : June 30, 2021
Estimated Study Completion Date : June 30, 2021